GIP and metabolic dysfunction-associated steatotic liver disease: Towards this direction a multi-omics approach was followed and it was checked whether GDF15, C-peptide, and GIP levels correlate with any of the metabolites or lipids in all individuals (subjects with MASLD and controls).